Skip to main content
Equibles

Colleen Cousy

Analyst

Baird

Equibles does not estimate personal net worth.

About Colleen Cousy

Colleen Cousy is recorded as Analyst at Baird. Colleen Cousy has spoken on 3 earnings calls across 3 companies, most recently for Coherus Oncology, Inc. on May 11, 2026. Those appearances were for Coherus Oncology, Inc. (CHRS), Iovance Biotherapeutics, Inc. (IOVA) and Agenus Inc (AGEN). The companies whose calls Colleen Cousy spoke on are classified in the Healthcare sector.

Colleen Cousy on recent calls

“I just had a quick one on the CasDozo program. So between AtezoBev and ToriBev as the backbone and combination there, do you expect to see any differences in the efficacy or safety profile?”
Analyst — Baird, Coherus Oncology, Inc. Q1 FY2026 Earnings Call ·
“On the community ATCs that you're seeing come online, can you just speak to the capacity that you see at those centers versus what the capacity is that you're seeing at the academic centers?”
Analyst — Baird, Iovance Biotherapeutics, Inc. Q3 FY2025 Earnings Call ·
“Have you had any interactions yet with the new FDA at this point ahead of the Part B meeting? And can you provide a little more color on the publication that you mentioned that led the FDA to its conclusion last summer and why you think that might be a different situation this summer?”
Analyst — Baird, Agenus Inc Q1 FY2025 Earnings Call ·

Affiliation history

  • Baird

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity